SUPN earnings
Supernus Pharmaceuticals (SUPN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
SUPN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | 0.35 | 0.49 | -28.57% | $226.77M |
| Q2 2026 | Aug 3, 2026 | 0.54 | 0.42 | 27.81% | $219.06M |
| Q1 2026 | May 5, 2026 | 0.59 | 0.28 | 110.71% | $207.71M |
| Q4 2025 | Feb 24, 2026 | 0.92 | 0.28 | 228.57% | $211.57M |
| Q3 2025 | Nov 4, 2025 | 1.01 | 0.82 | 23.17% | $192.10M |
| Q2 2025 | Aug 5, 2025 | 0.91 | 0.47 | 93.62% | $165.45M |
| Q1 2025 | May 6, 2025 | 0.42 | 0.38 | 10.53% | $149.82M |
| Q4 2024 | Feb 25, 2025 | 0.75 | 0.46 | 63.04% | $174.16M |
| Q3 2024 | Nov 4, 2024 | 1.06 | 0.39 | 171.79% | $175.69M |
| Q2 2024 | Aug 6, 2024 | 0.36 | 0.37 | -2.70% | $168.32M |
| Q1 2024 | May 8, 2024 | 0.26 | 0.38 | -31.58% | $143.64M |
| Q4 2023 | Feb 27, 2024 | 0.02 | 0.41 | -95.12% | $164.31M |
| Nov 8, 2023 | -0.29 | 0.13 | -323.08% | – | |
| Aug 8, 2023 | -0.02 | 0.23 | -108.70% | – | |
| May 9, 2023 | 0.29 | 0.17 | 70.59% | – | |
| Feb 28, 2023 | 0.43 | 0.68 | -36.76% | – | |
| Nov 8, 2022 | 0.03 | 0.36 | -91.67% | – | |
| Aug 4, 2022 | 0.14 | 0.29 | -51.72% | – | |
| May 9, 2022 | 0.43 | 0.26 | 65.38% | – | |
| Feb 28, 2022 | 0.04 | 0.24 | -81.34% | – |
- SUPN beat EPS estimates in 41 of its last 58 reports.
Updated 2026-11-02 20:40 UTC